PCYN — Procyon Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $0.98m
- $0.19m
- $4.98m
Annual income statement for Procyon, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K/A | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4.33 | 4.72 | 4.84 | 4.69 | 4.98 |
| Cost of Revenue | |||||
| Gross Profit | 3.2 | 3.39 | 3.49 | 3.57 | 3.89 |
| Selling / General / Administrative Expenses | |||||
| Total Operating Expenses | 4.18 | 4.49 | 5.08 | 4.78 | 5.22 |
| Operating Profit | 0.153 | 0.227 | -0.237 | -0.097 | -0.232 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.16 | 0.734 | -0.235 | -0.065 | -0.171 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.112 | 0.694 | -0.21 | -0.05 | -0.341 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.112 | 0.694 | -0.21 | -0.05 | -0.341 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.095 | 0.678 | -0.227 | -0.067 | -0.313 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.012 | 0.048 | -0.028 | -0.008 | -0.038 |